Tectonic Therapeutic Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Tectonic Therapeutic, Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2014
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2014
Revenue & Gross Profit
Revenue0.000.080.020.000.000.000.000.14
Cost of Revenue0.000.002.970.000.000.000.000.00
Gross Profit0.00-2.04-2.950.000.000.000.000.14
Operating Expenses
Research & Development41.3636.9725.6510.9887.2454.9735.100.00
Selling, General & Administrative16.657.687.184.6332.9920.8411.150.00
Operating Expenses58.0244.6532.8315.61120.2375.8146.240.00
Operating Income-58.02-44.65-32.83-15.61-120.23-75.81-46.240.00
Other Income/Expense
Interest Income4.260.580.150.000.000.001.730.00
Interest Expense0.11-0.150.140.450.000.000.000.00
Other Income/Expense-4.121.400.657.13-0.520.09-1.840.00
Income
Income Before Tax-57.98-42.82-32.18-8.93-119.71-72.97-46.360.00
Income Tax Expense0.00-14.570.000.000.000.000.000.00
Net Income-57.98-42.82-32.18-8.93-119.71-72.97-46.360.01
Net Income - Continuous Operations-57.98-42.82-32.18-8.930.000.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.000.00
EBITDA-56.23-43.17-31.03-8.12-119.02-72.12-45.860.00
EBIT-57.88-44.65-32.04-8.48-120.23-72.97-46.240.00
Depreciation & Amortization1.651.481.010.361.21-0.850.000.00
Earnings Per Share
Basic EPS-7.00-34.00-2.00-1.00-3.00--4.00-
Diluted EPS-7.00-34.00-2.00-1.00-3.00-3.00-4.00-
Basic Shares Outstanding8.491.2714.7314.7336.2127.4313.440.00
Diluted Shares Outstanding8.491.2714.7314.7336.2127.4313.440.00